Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Aventis Stories

2012-08-14 10:24:43

PARSIPPANY, N.J. and MUMBAI, India, Aug. 14, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuzosin hydrochloride, which is used in treatment of Benign Prostatic Hyperplasia or enlarged prostate. Alfuzosin is the generic name for the brand Uroxatral(®), marketed in the United States by Sanofi-Aventis. Wockhardt is launching the...

2012-01-22 08:00:00

Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, is proud to offer Chattem´s branded over-the-counter products and functional toiletries, some examples being Icy Hot ® and Gold Bond ®. Elberton, GA (PRWEB) January 22, 2012 Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, is proud to offer Chattem´s branded over-the-counter products and functional toiletries, some examples being Icy Hot...

2012-01-05 07:46:00

BRIDGEWATER, N.J., Jan. 5, 2012 /PRNewswire/ -- Sanofi US today announced that the U. S. District Court in Massachusetts granted the company a preliminary injunction against a Synvisc-One(®) (hylan G-F 20) competitor product developed by Seikagaku Corporation. The ruling allows for a restricted launch of Seikagaku's product prior to a scheduled trial date in April, and prohibits Seikagaku from selling their product below the current average sales price for Synvisc-One....

2011-10-26 06:00:00

SEATTLE, Oct. 26, 2011 /PRNewswire/ -- Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease, cancer and allergy, announced today that it has entered into an early-stage research collaboration with Sanofi-Aventis to investigate the use of IDC's Glucopyranosyl Lipid Adjuvant (GLA) technology, a toll-like receptor 4 (TLR-4) agonist, in the field of allergy. (Logo:...

2011-09-23 09:36:00

BRIDGEWATER, N.J., Sept. 23, 2011 /PRNewswire/ -- Take Care Health Systems, a wholly-owned subsidiary of Walgreens (NYSE, NASDAQ: WAG), and Sanofi US today announced the opening of a full-service medical center and on-site pharmacy at Sanofi's US headquarters in Bridgewater, New Jersey. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) "As a global health care company that is dedicated to solving health challenges, it is essential for us to know that we are doing...

2011-07-22 08:07:00

PARIS, July 22, 2011 /PRNewswire/ -- Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Greg Irace, currently President and CEO of Sanofi's US operations, to the newly created role of Senior Vice President, Global Services. In his new role, Greg will lead the Global Information Systems function, be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared...

2011-07-19 16:00:00

MISSISSAUGA, Ontario, July 19, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that its subsidiary, Valeant International (Barbados) SRL ("VIB"), has entered into an agreement with sanofi-aventis Canada Inc. ("sanofi-aventis") for the Canadian marketing and distribution rights to Zuacta(TM), a topical cream of zucapsaicin, which is indicated to be used in conjunction with oral COX-2 inhibitors or NSAIDs for the relief of severe pain...

2011-07-06 08:30:00

CHICAGO, July 6, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: United Parcel Services (NYSE: UPS), FedEx Corporation (NYSE: FDX), Bayer (OTC: BAYRY) , Johnson & Johnson (NYSE: JNJ) and Sanofi-Aventis (NYSE: SNY). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)...

2011-06-29 11:00:00

PARIS, June 29, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it entered into a research collaboration with Weill Cornell Medical College to develop new anti-infectives that aim to shorten the course of treatment of tuberculosis (TB) and provide effective therapies against drug-susceptible and drug-resistant strains of TB. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Under the terms of the collaboration, Sanofi will provide 80,000...

2011-06-21 00:00:29

Sanofi-Aventis, Duke Clinical Research and Telerx Marketing share their experience with Microsoft SharePoint® in a new Axendia White Paper Yardley, PA (PRWEB) June 20, 2011 Leading Life Science and Healthcare organizations, including Sanofi-Aventis, Duke Clinical Research and Telerx Marketing reported first-hand accounts of their experience with Microsoft SharePoint® -based solutions in a White Paper released today by the analyst and strategic advisory firm Axendia, Inc. "As we...